{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:09:16Z","timestamp":1782508156752,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.acvd.2025.03.121","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T20:52:46Z","timestamp":1744318366000},"page":"400-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Underestimated vascular dysfunction is a critical feature of the impaired cardiovascular profile in patients with transthyretin amyloidosis"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4432-5566","authenticated-orcid":false,"given":"Astrid","family":"Monfort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie","family":"Thevenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Inamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Neviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2025.03.121_bib0210","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40120-020-00210-7","article-title":"Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies","volume":"9","author":"Koike","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.acvd.2025.03.121_bib0215","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2025.03.121_bib0220","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/ehf2.13541","article-title":"Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT","volume":"8","author":"Nativi-Nicolau","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0225","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehm066","article-title":"Vascular abnormalities in primary amyloidosis","volume":"28","author":"Modesto","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.03.121_bib0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijcard.2022.06.035","article-title":"Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study","volume":"363","author":"Stamatelopoulos","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.03.121_bib0240","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ejhf.899","article-title":"Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis","volume":"19","author":"Clemmensen","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0245","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/ehf2.14621","article-title":"Invasive haemodynamics at rest and exercise in cardiac amyloidosis","volume":"11","author":"Holt","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.amjcard.2023.01.014","article-title":"Significance of pulmonary hypertension in cardiac amyloidosis","volume":"192","author":"Longinow","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13506129.2020.1722098","article-title":"Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy","volume":"27","author":"Monfort","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2025.03.121_bib0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/13506129.2019.1582024","article-title":"Chronotropic incompetence and autonomic dysfunction as mechanisms of dyspnoea in patients with late stage cardiac amyloidosis","volume":"26","author":"Nativi-Nicolau","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2025.03.121_bib0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ejhf.2016","article-title":"Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis","volume":"23","author":"Nicol","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0270","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/j.2040-4603.2012.tb00419.x","article-title":"Oxygen uptake kinetics","volume":"2","author":"Poole","year":"2012","journal-title":"Compr Physiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0275","doi-asserted-by":"crossref","first-page":"H1050","DOI":"10.1152\/ajpheart.00943.2011","article-title":"Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance","volume":"302","author":"Poole","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0280","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ejhf.3137","article-title":"Myocardial perfusion in cardiac amyloidosis","volume":"26","author":"Chacko","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0285","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0290","doi-asserted-by":"crossref","first-page":"838","DOI":"10.7326\/0003-4819-131-11-199912070-00007","article-title":"Systemic amyloidosis presenting with angina pectoris","volume":"131","author":"Al Suwaidi","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2025.03.121_bib0295","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.carpath.2006.09.011","article-title":"Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis","volume":"16","author":"Wittich","year":"2007","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0300","doi-asserted-by":"crossref","first-page":"H2305","DOI":"10.1152\/ajpheart.00503.2011","article-title":"Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins","volume":"301","author":"Migrino","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0305","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5858\/arpa.2016-0102-RA","article-title":"Amyloidosis of the lung","volume":"141","author":"Khoor","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.acvd.2025.03.121_bib0310","doi-asserted-by":"crossref","first-page":"106761","DOI":"10.1016\/j.rmed.2022.106761","article-title":"Clinical, radiologic, and pathologic features and outcomes of pulmonary transthyretin amyloidosis","volume":"194","author":"Eggleston","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.acvd.2025.03.121_bib0315","first-page":"1051","article-title":"Amyloidosis of the aortic root in a patient with polyarteritis nodosa","volume":"38","author":"Gasparovic","year":"2014","journal-title":"Coll Antropol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0320","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jcu.22547","article-title":"Cardiac amyloidosis is associated with increased aortic stiffness","volume":"46","author":"Nemes","year":"2018","journal-title":"J Clin Ultrasound"},{"key":"10.1016\/j.acvd.2025.03.121_bib0325","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/CIRCRESAHA.119.314862","article-title":"Reactive vasodilation predicts mortality in primary systemic light-chain amyloidosis","volume":"125","author":"Stamatelopoulos","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.acvd.2025.03.121_bib0330","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ehf2.13792","article-title":"Eyes on amyloidosis: microvascular retinal dysfunction in cardiac amyloidosis","volume":"9","author":"Zampiccoli","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0335","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.3390\/jcm12072534","article-title":"Endothelial function is preserved in patients with wild-type transthyretin amyloid cardiomyopathy","volume":"12","author":"Hashimoto","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.acvd.2025.03.121_bib0340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2018.09.011","article-title":"The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: an ultrastructural study","volume":"394","author":"Koike","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.acvd.2025.03.121_bib0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/13506129.2019.1582496","article-title":"Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study","volume":"26","author":"Koike","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2025.03.121_bib0350","doi-asserted-by":"crossref","first-page":"1174643","DOI":"10.3389\/fmed.2023.1174643","article-title":"OCT angiography indices and the choroidal vascularity index in wild-type transthyretin (TTR) amyloidosis (ATTRwt)","volume":"10","author":"Rinaldi","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.acvd.2025.03.121_bib0355","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1038\/s41598-022-15779-2","article-title":"A pilot study of nailfold capillaroscopy in hereditary transthyretin amyloidosis","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.acvd.2025.03.121_bib0360","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/ejhf.2298","article-title":"The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease","volume":"23","author":"Aimo","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0365","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s00421-021-04756-8","article-title":"Muscle metaboreflex adaptations to exercise training in health and disease","volume":"121","author":"Gama","year":"2021","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0370","doi-asserted-by":"crossref","first-page":"1174645","DOI":"10.3389\/fphys.2023.1174645","article-title":"The ventilatory component of the muscle metaboreflex is overstimulated in transthyretin cardiac amyloidosis patients with poor aerobic capacity","volume":"14","author":"Monfort","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0375","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","article-title":"Conventional heart failure therapy in cardiac ATTR amyloidosis","volume":"44","author":"Ioannou","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2025.03.121_bib0380","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2025.03.121_bib0385","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/13506129.2024.2431082","article-title":"Clinical impact of beta-blocker withdrawal in transthyretin amyloid cardiomyopathy","volume":"32","author":"Cabrera-Romero","year":"2025","journal-title":"Amyloid"},{"key":"10.1016\/j.acvd.2025.03.121_bib0390","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/jcm13082257","article-title":"Prognostic value of standard heart failure medication in patients with cardiac transthyretin amyloidosis","volume":"13","author":"Aus dem Siepen","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.acvd.2025.03.121_bib0395","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jccase.2023.04.011","article-title":"Hemodynamic testing to guide vasodilator therapy in cardiac amyloidosis","volume":"28","author":"Rucker","year":"2023","journal-title":"J Cardiol Cases"},{"key":"10.1016\/j.acvd.2025.03.121_bib0400","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2047487315588391","article-title":"Chronic heart failure and aging\u00a0\u2013\u00a0effects of exercise training on endothelial function and mechanisms of endothelial regeneration: results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study","volume":"23","author":"Sandri","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0405","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cjca.2023.12.014","article-title":"Exercise intervention for patients with transthyretin amyloid cardiomyopathy (EXCITE-ATTR-CM) pilot study","volume":"40","author":"Rivera-Theurel","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.acvd.2025.03.121_bib0410","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/13506129.2022.2043270","article-title":"Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"29","author":"Barroso","year":"2022","journal-title":"Amyloid"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213625002177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213625002177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T12:35:13Z","timestamp":1747917313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213625002177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":41,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1875213625002177"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2025.03.121","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underestimated vascular dysfunction is a critical feature of the impaired cardiovascular profile in patients with transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2025.03.121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}